Loading...
Loading...
Browse all stories on DeepNewz
VisitWill Quanterix complete the acquisition of Akoya Biosciences by June 30, 2025?
Yes • 50%
No • 50%
Official press releases from Quanterix or Akoya Biosciences, or financial news outlets
Quanterix to Acquire Akoya Biosciences in All-Stock Deal for First Integrated Solution in Ultra-Sensitive Biomarker Detection
Jan 10, 2025, 11:37 AM
Quanterix Corporation has reached an agreement to acquire Akoya Biosciences in an all-stock transaction. This merger aims to create the first integrated solution for ultra-sensitive detection of blood- and tissue-based protein biomarkers, enhancing capabilities in disease detection at various stages. Both companies are recognized for their contributions to life sciences, with Quanterix focusing on advanced biomarker detection technologies and Akoya specializing in spatial biology solutions. The deal is expected to combine their strengths and improve diagnostic capabilities in the healthcare sector.
View original story
No • 50%
Yes • 50%
Yes • 50%
No • 50%
Antonio Gracias acquires controlling stake • 25%
Other outcome • 25%
Deal falls through for other reasons • 25%
Helena vetoes the deal • 25%
No • 50%
Yes • 50%
2-3 • 25%
4 or more • 25%
0 • 25%
1 • 25%
Increase by less than 10% • 25%
Increase by more than 30% • 25%
Decrease • 25%
Increase by 10-30% • 25%